288 related articles for article (PubMed ID: 23651642)
1. Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364.
Sotthivirat S; McKelvey C; Moser J; Rege B; Xu W; Zhang D
Int J Pharm; 2013 Aug; 452(1-2):73-81. PubMed ID: 23651642
[TBL] [Abstract][Full Text] [Related]
2. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
4. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
5. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
Sarode AL; Sandhu H; Shah N; Malick W; Zia H
Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Effect of Polyvinyl Alcohol and Copovidone in Itraconazole Amorphous Solid Dispersions.
Wlodarski K; Zhang F; Liu T; Sawicki W; Kipping T
Pharm Res; 2018 Jan; 35(1):16. PubMed ID: 29305665
[TBL] [Abstract][Full Text] [Related]
7. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
8. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
9. Characterization and performance assessment of solid dispersions prepared by hot melt extrusion and spray drying process.
Agrawal AM; Dudhedia MS; Patel AD; Raikes MS
Int J Pharm; 2013 Nov; 457(1):71-81. PubMed ID: 24013161
[TBL] [Abstract][Full Text] [Related]
10. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
11. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release.
Solanki NG; Lam K; Tahsin M; Gumaste SG; Shah AV; Serajuddin ATM
J Pharm Sci; 2019 Apr; 108(4):1453-1465. PubMed ID: 30395834
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of solubility and oral bioavailability of manidipine by formation of ternary solid dispersion with d-α-tocopherol polyethylene glycol 1000 succinate and copovidone.
Chamsai B; Limmatvapirat S; Sungthongjeen S; Sriamornsak P
Drug Dev Ind Pharm; 2017 Dec; 43(12):2064-2075. PubMed ID: 28836855
[TBL] [Abstract][Full Text] [Related]
13. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
14. Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study.
Kennedy M; Hu J; Gao P; Li L; Ali-Reynolds A; Chal B; Gupta V; Ma C; Mahajan N; Akrami A; Surapaneni S
Mol Pharm; 2008; 5(6):981-93. PubMed ID: 19434920
[TBL] [Abstract][Full Text] [Related]
15. Hot Melt Extrusion and Spray Drying of Co-amorphous Indomethacin-Arginine With Polymers.
Lenz E; Löbmann K; Rades T; Knop K; Kleinebudde P
J Pharm Sci; 2017 Jan; 106(1):302-312. PubMed ID: 27817830
[TBL] [Abstract][Full Text] [Related]
16. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets.
Solanki NG; Kathawala M; Serajuddin ATM
J Pharm Sci; 2019 Dec; 108(12):3859-3869. PubMed ID: 31542437
[TBL] [Abstract][Full Text] [Related]
17. Amorphous-based controlled-release gliclazide matrix system.
Lu Z; Yang Y; Covington RA; Bi YV; Dürig T; Fassihi R
AAPS PharmSciTech; 2017 Jul; 18(5):1699-1709. PubMed ID: 27714702
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of emulsified solid dispersions containing docetaxel.
Chen Y; Shi Q; Chen Z; Zheng J; Xu H; Li J; Liu H
Arch Pharm Res; 2011 Nov; 34(11):1909-17. PubMed ID: 22139690
[TBL] [Abstract][Full Text] [Related]
19. Physical and dissolution characterization of cilostazol solid dispersions prepared by hot melt granulation (HMG) and thermal adhesion granulation (TAG) methods.
Chen YC; Ho HO; Chiou JD; Sheu MT
Int J Pharm; 2014 Oct; 473(1-2):458-68. PubMed ID: 25089508
[TBL] [Abstract][Full Text] [Related]
20. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
